Related by context. All words. (Click for frequent words.) 68 anti TNF 65 immunomodulatory 65 biologic therapy 64 anti angiogenic 64 proteasome inhibitors 64 therapies 64 antithrombotic 64 vascular disrupting agent 64 TNF alpha inhibitors 64 Tyrima 64 investigational compound 63 LY# [003] 63 pharmacologic 63 therapeutics 63 anticancer agent 63 neuroprotective 63 Serdaxin 63 small molecule 62 TNF alpha inhibitor 62 disease modifying antirheumatic 62 tocilizumab 62 TNF inhibitor 62 receptor tyrosine kinase inhibitor 62 tyrosine kinase inhibitors 62 DMARD 62 immunotherapy 62 anti VEGF 62 relapsing remitting multiple sclerosis 62 small molecule inhibitors 62 lupus nephritis 62 molecularly targeted 62 pertuzumab 61 antipsychotic 61 dasatinib Sprycel 61 HSP# inhibitor 61 Mipomersen 61 proteasome inhibitor 61 TNF inhibitors 61 imatinib Gleevec ® 61 BAY #-# 61 orally bioavailable 61 tezampanel 61 bendamustine 61 angiogenesis inhibitor 61 vidofludimus 61 Symadex 61 insulin sensitizers 61 diabetic neuropathic pain 61 HDAC inhibitors 61 kinase inhibitors 61 renin inhibitors 61 otelixizumab 61 receptor antagonists 61 Laquinimod 61 mTOR inhibitors 61 immunotherapeutic 61 adalimumab Humira 60 dasatinib 60 DMARDs 60 myelofibrosis 60 uric acid lowering 60 NGX# 60 PRX # 60 calcineurin inhibitors 60 Parkinson disease PD 60 anticancer agents 60 orally administered 60 Nanobody 60 PSN# [002] 60 anti leukemic 60 Hsp# inhibition 60 INCB# [001] 60 Bortezomib 60 Xanafide 60 imatinib Gleevec 60 TRV# [001] 60 SARMs 60 atypical antipsychotic 60 Traficet EN 60 biologic therapies 60 investigational drug 60 angiotensin receptor blocker ARB 60 KRN# 60 triptans 60 antidiabetic 60 SNRI 60 sorafenib Nexavar 60 PXD# 60 neuropathic pain 60 lipid lowering 60 anti TNF alpha 60 polymerase inhibitor 60 diabetic nephropathy 60 multitargeted 60 HGS# 60 heavily pretreated 60 histone deacetylase HDAC inhibitor 59 anti angiogenesis 59 oral antiviral 59 erlotinib Tarceva ® 59 YONDELIS 59 MEK inhibitors 59 insulin sensitizer 59 triptan 59 pomalidomide 59 CA4P 59 Tasimelteon 59 anticancer therapies 59 PDE4 inhibitor 59 schizophrenia CIAS 59 Nexavar ® 59 siRNA therapeutics 59 investigational therapies 59 multi kinase inhibitor 59 tanespimycin 59 cancer therapeutics 59 AP# [003] 59 bexarotene 59 Ceflatonin 59 PD LID 59 tipifarnib 59 INT# [002] 59 memantine 59 Valdoxan 59 ProSavin 59 investigational humanized monoclonal antibody 59 histone deacetylase inhibitors 59 immunomodulatory therapy 59 Archexin 59 receptor agonists 59 relapsing forms 59 BCR ABL inhibitors 59 Dasatinib 59 vascular disrupting agents 59 sodium glucose cotransporter 59 insulin sensitizing 59 Debio 59 daclizumab 59 epothilone 59 Anti TNF 59 taxane 59 immunomodulating 59 JAK inhibitor 59 cholinesterase inhibitors 59 acting muscarinic antagonist 59 preclinical studies 59 tyrosine kinase inhibitor 59 Vilazodone 59 kinase inhibitor 59 TriRima 59 HuLuc# 58 biomarker 58 Novartis Gleevec 58 Zolinza 58 Imatinib 58 Pertuzumab 58 LHRH antagonists 58 Pazopanib 58 TREANDA 58 Alemtuzumab 58 IMiDs 58 OncoVEX GM CSF 58 SNT MC# 58 mTOR inhibitor 58 nucleoside analogues 58 zileuton 58 SERMs 58 enzastaurin 58 RNAi therapeutic targeting 58 neuroprotection 58 metaglidasen 58 eltrombopag 58 anticholinergic 58 phase IIa clinical 58 Azilect ® 58 Talabostat 58 immune modulatory 58 PARP inhibitors 58 dasatinib Sprycel ® 58 etanercept 58 anti TNFs 58 obatoclax 58 pharmacological 58 anti angiogenic therapy 58 neuroprotective properties 58 Bicifadine 58 ALN TTR 58 decitabine 58 TKIs 58 Seliciclib 58 AMN# [001] 58 receptor antagonist 58 protein kinase inhibitors 58 interferon beta 58 relapsed multiple myeloma 58 sapacitabine 58 Catena ® 58 atacicept 58 PRT# 58 mGluR2 NAM 58 relapsing multiple sclerosis 58 preclinical 58 IMGN# 58 Hsp# inhibitors 58 Azixa 58 Bevacizumab 58 SCH # 58 preclinically 58 selective modulator 58 protein therapeutics 58 direct thrombin inhibitors 58 subcutaneously administered 58 anticancer therapy 58 tafamidis 58 Golimumab 58 TELINTRA 58 therapeutic 58 Fx #A 58 bapineuzumab 58 GPCRs 58 VEGF inhibitors 58 RNAi therapeutics 58 Gefitinib 58 immunosuppressant 58 entacapone 58 antitumor 58 talabostat 58 antisense drug 58 Ceflatonin R 58 Herceptin trastuzumab 58 antihypertensive 58 CCR9 antagonist 58 HuMax CD4 58 macrolide antibiotics 58 novel histone deacetylase 58 NNRTI 58 Sapacitabine 58 Plicera 58 interferon therapy 58 adalimumab 58 JAK3 inhibitor 58 erlotinib 58 Pimavanserin 58 chemoprevention 58 humanized monoclonal antibody 58 CCX# 58 glucose lowering 57 ganetespib 57 Epothilones 57 Interferon alpha 57 oral anticoagulant 57 thetreatment 57 RhuDex ® 57 trabectedin 57 CCR5 antagonist 57 Kuvan 57 viral kinetics 57 IAP inhibitor 57 cetuximab Erbitux R 57 anti mitotic 57 beta secretase inhibitors 57 SERCA2a 57 pegylated 57 pharmacological chaperone 57 regorafenib 57 galantamine 57 Tamibarotene 57 epigenetic therapies 57 XmAb# 57 mapatumumab 57 integrase inhibitor 57 immunomodulator 57 nilotinib Tasigna ® 57 perampanel 57 disease progression 57 novel anticancer 57 rheumatoid arthritis RA 57 somatostatin analogue 57 pan HDAC inhibitor 57 teriparatide 57 cardiac toxicity 57 PKC# 57 selective inhibition 57 peripherally acting 57 IAP inhibitors 57 PRTX 57 Aflibercept 57 selective inhibitors 57 sunitinib malate 57 Orazol 57 xanthine oxidase inhibitor 57 antitumoral 57 visilizumab 57 Rasagiline 57 velafermin 57 epothilones 57 dyslipidemia 57 antihypertensive agents 57 bosutinib 57 interferon alpha 57 immune modulating 57 tubulin inhibitor 57 azacitidine 57 MAP# 57 echinocandin 57 Phase 2a trial 57 donepezil Aricept 57 bevacizumab Avastin ® 57 perifosine 57 ELND# 57 neurodegenerative diseases 57 PI3K/mTOR 57 Clofarabine 57 Dapagliflozin 57 Phase Ib study 57 vorinostat 57 monoclonal antibody 57 dexanabinol 57 NEUGENE 57 CBLC# 57 small molecule inhibitor 57 allopurinol 57 generation purine nucleoside 57 Preclinical studies suggest 57 PNP inhibitor 57 PsA 57 tamibarotene 57 RNAi therapeutic 57 metastatic renal cell carcinoma 57 ATL/TV# 57 delta isoform 57 ANG# 57 riociguat 57 small molecule defensin 57 Doxil ® 57 Omacetaxine 57 Pegasys ® 57 Viprinex 57 Daclizumab 57 BCR ABL inhibitor 57 Triolex 57 anti amnesic 57 Elesclomol 57 chemopreventive agent 57 Bruton tyrosine kinase Btk 57 Cytolin R 57 pegylated interferons 57 leukotriene receptor antagonist 57 temozolomide 57 AZILECT ® 57 Arcalyst 57 Gleevec resistant 57 dexpramipexole 57 paclitaxel Taxol 57 chemotherapeutics 57 multikinase inhibitor 57 novel VDA molecule 57 vandetanib 57 temsirolimus 57 ACTEMRA 57 VEGF receptor 57 AVONEX ® 57 CDK inhibitor 57 Marqibo 57 alemtuzumab 57 receptor agonist 57 chemotherapeutic agents 57 AZD# 57 NNRTIs 57 SGLT inhibitors 57 lapatinib Tykerb 57 PEGylated interferon beta 1a 57 IGIV 57 JAK2 inhibitor 57 LymphoStat B 57 PLX# 57 cannabinor 57 AZILECT R 57 sunitinib 57 OXi# 57 Phase IIb trials 57 docetaxel 57 T#I mutation 57 protein kinase inhibitor 57 Panzem R 57 investigational oral 57 posaconazole 57 Vidofludimus 57 Miraxion 57 antibody MAb 57 teriflunomide 57 Janus kinase 56 imatinib mesylate 56 opioid induced constipation 56 anticonvulsant 56 rituximab 56 olaparib 56 Azedra 56 biomarkers 56 systemic fungal infections 56 placebo controlled clinical 56 ZOLINZA 56 ANAVEX #-# [003] 56 Stedivaze 56 Carfilzomib 56 Lu AA# 56 pharmacologic intervention 56 tiapamil 56 cetuximab 56 anti rheumatic 56 intravenously administered 56 VEGF inhibitor 56 bortezomib 56 panitumumab Vectibix 56 BNC# 56 BRAF inhibitor 56 oral FTY# 56 Adalimumab 56 Tocilizumab 56 small molecule activators 56 carvedilol 56 forodesine 56 dexamethasone Decadron 56 factor Xa inhibitor 56 NVA# 56 novel peptide 56 long acting muscarinic 56 glatiramer acetate 56 gefitinib Iressa 56 superficial bladder cancer 56 JAK inhibitors 56 Abiraterone 56 COPAXONE R 56 bevacizumab Avastin 56 VAPRISOL 56 selective HDAC inhibitors 56 AEG# 56 Panzem 56 CoFactor 56 entinostat 56 CYC# 56 p# inhibitor 56 small molecule tyrosine 56 RDEA# 56 fingolimod 56 interferon 56 DXL# 56 Vorinostat 56 lumiliximab 56 Synavive 56 oral prodrug 56 nilotinib Tasigna 56 Torisel 56 TLR8 agonist 56 Rotigotine 56 Icatibant 56 vilazodone 56 Perifosine 56 Eltrombopag 56 refractory Hodgkin lymphoma 56 PEGylated Fab fragment 56 tyrosine kinase inhibitor TKI 56 INC# 56 PEG Interferon lambda 56 taxanes 56 Combination therapy 56 HCV protease inhibitors 56 Actemra 56 erlotinib Tarceva 56 targeted radiotherapeutic 56 elotuzumab 56 ZYBRESTAT 56 synthetic retinoid 56 dimebon 56 rFVIIIFc 56 ADX# 56 JAK1 56 Promacta 56 antithrombotics 56 Arimoclomol 56 hyperuricemia 56 YONDELIS R 56 deacetylase inhibitors 56 immunomodulators 56 protease inhibitors 56 chronic lymphocytic leukemia CLL 56 Tarceva erlotinib 56 aromatase inhibitor 56 infliximab 56 ACZ# 56 CD# antibody [001] 56 #ME# 56 immune modulation 56 nucleoside analogue 56 Azilect 56 levodopa carbidopa 56 Nuvion 56 idiopathic pulmonary fibrosis IPF 56 therapeutic interventions 56 DFMO 56 Elagolix 56 Blinatumomab 56 recurrent GBM 56 neuroregenerative 56 imatinib therapy 56 GPCR targets 56 cilengitide 56 Phenoptin 56 factor TNF 56 talactoferrin 56 receptor modulators 56 anti anginal 56 Campath alemtuzumab 56 glufosfamide 56 anticancer drugs 56 immunotherapies 56 Anticalins 56 phase IIb clinical 56 OMAPRO 56 imatinib 56 GLPG# 56 Tofacitinib 56 interferon beta therapy 56 antiplatelet 56 histone methyltransferases HMTs 56 Safinamide 56 MDV# 56 agomelatine 56 Phase Ib clinical 56 Pirfenidone 56 Milnacipran 56 Amrubicin 56 Rebif ® 56 nilotinib 56 Pralatrexate 56 beta interferons 56 ixabepilone 56 beta 1a 56 oral antidiabetic 56 Omnitarg 56 HCV polymerase inhibitors 56 anti fibrotic 56 preclinical models 56 rheumatoid arthritis 56 NMDA antagonist 56 IMiD 56 chemotherapeutic 56 IRESSA 56 CIMZIA ™ 56 tigecycline 56 Firazyr 56 axitinib 56 selective inhibitor 56 antihypertensive therapy 56 HQK 56 imetelstat 56 NIC5 56 CR# vcMMAE 56 molecular biomarkers 56 selective antagonist 56 Huntexil 56 Plecanatide 56 Nanobody ® 56 TRIOLEX 56 Maribavir 56 Anavex #-# 56 eculizumab 56 fluoropyrimidine 56 Cethromycin 56 mycophenolate mofetil 56 Exelixis compounds 56 lapatinib 56 JAK3 56 liposomal formulation 56 metastatic RCC 56 Targretin 56 Personalized Immunotherapy 56 humanized anti 56 rNAPc2 56 baminercept 56 abatacept 56 Amigal 56 angiotensin converting enzyme inhibitors 55 cancer cachexia 55 6R BH4 55 Ocrelizumab 55 adipiplon 55 HCV 55 vemurafenib 55 gamma secretase inhibitors 55 ENMD # 55 R#/MEM # 55 C1 INH 55 DACH platinum 55 T DM1 55 Rilutek 55 Nanobodies 55 pharmacokinetic properties 55 alvespimycin 55 immunosuppressive 55 CDP# 55 favorable pharmacokinetic profile 55 INCB# [002] 55 leukemia AML 55 oral anticancer 55 inhibitor 55 Ranibizumab 55 Everolimus 55 mTOR kinase 55 antisense oligonucleotide 55 Vimpat R 55 monotherapy 55 SRT# [003] 55 Preclinical studies 55 Sphingomab 55 chronic myeloid leukemia CML 55 immunomodulatory agents 55 HDACi 55 olanzapine Zyprexa 55 Lialda 55 interferons 55 ATL# [001] 55 OXIGON TM 55 Phase III trials 55 PEG SN# 55 thalidomide Thalomid 55 MBP# [001] 55 gemcitabine 55 cytostatic 55 acute leukemias 55 HDAC inhibitor 55 TG# [003] 55 diabetic gastroparesis 55 opioid analgesic 55 donepezil 55 Clolar 55 Rheumatoid Arthritis RA 55 ALK inhibitor 55 MGCD# [001] 55 Xenazine 55 oral Factor Xa 55 BGC# 55 alemtuzumab Campath 55 AKT inhibitor 55 antiemetic 55 predictive biomarkers 55 DP b# 55 Bezielle 55 hour bronchodilation 55 Pixantrone 55 protease inhibitor PI 55 tramiprosate 55 beta interferon 55 Cloretazine 55 Menerba 55 oral gallium 55 dirucotide 55 antisense 55 chemotherapeutic drug 55 CEQ# 55 unmet medical 55 monoclonal antibodies 55 orally dosed 55 efficacy tolerability 55 rufinamide 55 oral cladribine 55 davunetide 55 dopamine agonists 55 therapeutic antibody 55 Fc fusion protein 55 Hedgehog pathway 55 omega interferon 55 LY# [002] 55 diarrhea predominant irritable 55 bortezomib Velcade 55 omalizumab 55 Mitoxantrone 55 Revimmune 55 mertansine 55 sorafenib tablets 55 ADAGIO study 55 Hsp# inhibitor 55 tolvaptan 55 #D#C# 55 infliximab Remicade 55 NNR Therapeutics 55 rHuPH# 55 5 HT6 receptor 55 nab paclitaxel 55 levetiracetam Keppra 55 oral antiplatelet 55 clofarabine 55 VDAs 55 Telintra 55 IL-#/# 55 torezolid phosphate 55 Sym# 55 LMWH 55 idarubicin 55 Phase IIa clinical 55 RRMS 55 TRO# 55 TNFα 55 Annamycin 55 CTAP# Capsules 55 APTIVUS r 55 PI3K inhibitors 55 isoform selective 55 Alzhemed TM 55 DMARDS 55 ALN PCS 55 OHR/AVR# 55 Aliskiren 55 siRNA delivery 55 bosentan 55 Lacosamide 55 Intravenous CP 55 peptibody 55 nitric oxide donating 55 Cyclooxygenase Inhibiting Nitric Oxide 55 Abiraterone acetate 55 rivastigmine Exelon 55 pramipexole 55 docetaxel Taxotere 55 TNF blocking 55 Phenserine 55 echinocandins 55 diabetic macular edema 55 BLyS specific 55 Remicade infliximab 55 vinorelbine 55 nucleoside analogs 55 oral antifungal 55 vinca alkaloid 55 Flurizan 55 Enzastaurin 55 mGluR5 NAM 55 cystinosis patients 55 Teriflunomide 55 Amplimexon 55 DDP# 55 Denufosol 55 microtubule targeting 55 hypomethylating agents 55 Panzem R NCD 55 acute myelogenous leukemia AML 55 targeted antifolate 55 Voreloxin 55 chemotherapies 55 novel immunomodulatory 55 seliciclib 55 hereditary deficiency 55 noninfectious uveitis 55 cutaneous T cell 55 anti secretory 55 signal transduction inhibitor 55 PKCi 55 HCV protease 55 formerly LymphoStat B 55 S/GSK# 55 agonists 55 mu opioid receptor antagonist 55 Onconase 55 Exenatide 55 depsipeptide 55 therapeutic monoclonal antibodies 55 GFT# 55 Dalbavancin 55 CYT# potent vascular disrupting 55 caspofungin 55 pharmacodynamic properties 55 antitumor activity 55 evaluating tivozanib 55 Doxil 55 LHON 55 neurotrophic factor 55 active ankylosing spondylitis 55 partial agonist 55 injectable formulation 55 Reverset 55 Vimpat ® 55 RNAi 55 abiraterone 55 non steroidal 55 immune modulators 55 anti hypertensive 55 developing Bicifadine serotonin 55 palifosfamide 55 relapsed ovarian cancer 55 CANCIDAS 55 surrogate endpoint 55 nucleoside analog 55 severe gastroparesis 55 Donepezil 55 intranasal delivery 55 Nanobodies ® 55 AEGR 55 NRTIs 55 Fabry Disease 55 IMiDs R 55 Belimumab 55 resolvin 54 antimetabolite 54 Factor VIIa 54 antiepileptic 54 reslizumab 54 carfilzomib 54 integrase inhibitors 54 neuraminidase inhibitors 54 antiarrhythmic 54 pharmacokinetic profile 54 anidulafungin 54 Natalizumab 54 Tarvacin 54 pharmacokinetic interactions 54 Degarelix 54 eosinophilic asthma 54 trastuzumab Herceptin 54 AMPK activators 54 progressive PsA 54 systemic lupus erythematosus SLE 54 VA# [002] 54 tumor vascular disrupting 54 vismodegib 54 AChE inhibitors 54 samalizumab 54 T#I [002] 54 Pagoclone 54 selegiline 54 lacosamide 54 refractory PTCL 54 pharmacotherapies 54 cangrelor 54 antiviral therapy 54 fenofibrate 54 Orencia 54 Revlimid lenalidomide 54 antiangiogenic 54 peritumoral brain edema 54 Lenalidomide 54 Curaxin 54 Levodopa 54 GLYX 54 chemotherapeutic agent 54 inhaled corticosteroid 54 Aurora kinase inhibitors 54 Zelapar 54 dipeptidyl peptidase IV 54 trastuzumab 54 nucleotide analogs 54 Roche Chugai s 54 Hedgehog signaling pathway 54 novel oral anticoagulant 54 interferon IFN 54 Mycamine 54 clinically meaningful 54 HGS ETR1 54 Troxatyl 54 TPI ASM8 54 antiviral therapeutics 54 Dimebon 54 Amphotericin B 54 pharmacodynamic PD 54 antiangiogenic agent 54 clobazam 54 ADP receptor antagonist 54 anti angiogenic drugs 54 targeting CD# 54 antagonist LAMA 54 IFN beta 54 siRNA therapeutic 54 cytotoxic chemotherapy 54 BENLYSTA TM 54 BENLYSTA 54 bucindolol 54 cetuximab Erbitux ® 54 Tarceva TM 54 5FU 54 RGB # 54 acute migraine 54 humanized monoclonal 54 refractory CTCL 54 IMC A# 54 estrogen receptor beta 54 Triapine 54 SGLT 2 54 Darusentan 54 Anidulafungin 54 dacetuzumab 54 castrate resistant prostate cancer 54 lipid lowering therapies 54 renin inhibitor 54 mirtazapine 54 oxaliplatin Eloxatin 54 EGFR antibodies 54 canagliflozin 54 virus HCV protease inhibitor 54 IV antihypertensive 54 carbidopa levodopa 54 CYT# 54 TLR9 agonist 54 antibody therapeutics 54 romidepsin 54 diagnostic biomarkers 54 Inhalation Solution 54 ON #.Na 54 pulmonary arterial hypertension PAH 54 Romidepsin 54 Bronchitol 54 antihypertensive drugs 54 olmesartan 54 APD# 54 Onalta ™ 54 miltefosine 54 ocrelizumab 54 refractory gout 54 pramlintide 54 panitumumab 54 topical NSAID 54 Phase IIa trial 54 IGF 1R 54 neurodegeneration 54 DPP4 inhibitor 54 rilonacept 54 oral formulation 54 HuMax CD# 54 glitazones 54 anticancer 54 mGluR4 54 selective androgen receptor modulator 54 LEP ETU 54 itraconazole 54 solanezumab 54 ZD# [001] 54 Silodosin 54 cytoprotective 54 Myelodysplastic Syndrome MDS 54 EOquin 54 AZILECT 54 rituximab Rituxan 54 cabazitaxel 54 polymerase inhibitors 54 either acutely decompensated 54 Atiprimod 54 neurotrophic 54 non alcoholic steatohepatitis 54 anti muscarinic 54 allosteric modulators 54 GAMMAGARD 54 nucleoside 54 Gemcitabine 54 aripiprazole Abilify 54 Erlotinib 54 Ambrisentan 54 engineered RAP peptides 54 acadesine 54 histone deacetylase inhibitor 54 pharmacologic agents 54 ASONEP 54 Taxotere ® 54 Ophena TM 54 investigational 54 gamma secretase inhibitor 54 ganaxolone 54 CG# [003] 54 picoplatin 54 INCB# [003] 54 Noxafil 54 MAGE A3 ASCI 54 Rituximab 54 chemically modified siRNA 54 anti thrombotic 54 MabThera rituximab 54 MLN# 54 TLK# 54 cardiotoxic 54 urate lowering 54 imatinib mesylate Gleevec 54 Interferon beta 54 mGluR2 54 G CSF 54 TACE 54 PI3K inhibitor 54 anakinra 54 pazopanib 54 menstrual migraine 54 incyclinide 54 Eribulin 54 Anticalin 54 oral anticoagulants 54 KSP inhibitors 54 investigational monoclonal antibody 54 neurogenic 54 MEK inhibitor 54 hedgehog pathway 54 RRMS patients 54 NP2 Enkephalin 54 PSN# [001] 54 Lamotrigine